PeptideDB

Elomotecan

CAS No.: 220998-10-7

Elomotecan (BN 80927 free base), a camptothecin analog from the homocamptothecin family (hCPT), serves as a potent inhib
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description Elomotecan (BN 80927 free base), a camptothecin analog from the homocamptothecin family (hCPT), serves as a potent inhibitor of topoisomerases I and II. It effectively reduces the proliferation of various tumor cells more significantly than other reference anticancer drugs targeting the same topoisomerases [1].This compound is unstable in powder form and other related salt forms are recommended.
In vitro WEHI-539 induces noticeable PARP cleavage in Ovcar-4 (5 μM in Ovcar-4.) and Ovsaho (1 μM in Ovsaho) cells. WEHI-539 augments Carboplatin induced caspase 3/7 activity, PARP cleavage, and annexin V labeling.[2]
Synonyms BN 80927 free base
molecular weight 522.04
Molecular formula C29H32ClN3O4
CAS 220998-10-7
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.